FDA Approved: FLUDEOXYGLUCOSE F-18 — Original Application (Cardinal Health 414, LLC)

View source ↗

Summary

FDA approved Fluorodeoxyglucose F-18 as a radiopharmaceutical for PET imaging to help identify and evaluate malignant lesions in oncology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fluorodeoxyglucose F-18 (Fluorodeoxyglucose F-18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F-18 (FLUDEOXYGLUCOSE F-18)